Oncternal Therapeutics (ONCT) SEC Filings & 10K Form

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free ONCT Stock Alerts

$8.60

-0.35 (-3.91%)

(As of 04/18/2024 ET)

Compare

Recent Oncternal Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/10/2024 7:38 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Wills Robert James (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
04/01/2024 6:00 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Wills Robert James (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/08/2024 3:42 PM	Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)	Form S-3 Registration statement under Securities Act of 1933
02/15/2024 5:00 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) VINCENT RICHARD G (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 5:00 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Yazji Salim (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 5:00 PM	Krishnan Rajesh (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 5:00 PM	Leavitt Chase C. (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 5:00 PM	BREITMEYER JAMES B (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
01/23/2024 3:05 PM	Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
10/06/2023 3:31 PM	Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
10/04/2023 3:59 PM	Krishnan Rajesh (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
10/04/2023 3:59 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) VINCENT RICHARD G (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/04/2023 4:00 PM	BREITMEYER JAMES B (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
10/04/2023 4:01 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Yazji Salim (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/04/2023 4:01 PM	Leavitt Chase C. (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
09/14/2023 3:01 PM	Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)	Form 8-K/A
07/05/2023 5:57 PM	Krishnan Rajesh (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 5:58 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Yazji Salim (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 5:58 PM	Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) VINCENT RICHARD G (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 5:59 PM	Leavitt Chase C. (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 5:59 PM	BREITMEYER JAMES B (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/29/2023 5:01 AM	Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/02/2023 3:31 PM	Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:ONCT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oncternal Therapeutics (ONCT) SEC Filings & 10K Form

Recent Oncternal Therapeutics SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info